全球儿童膀胱治疗市场 – 行业趋势及 2030 年预测

儿童膀胱治疗市场分析及规模

不健康的生活方式（如饮用冷饮和接触化学物质）推动了儿童膀胱治疗市场的增长。此外，儿童人群中焦虑和泌尿系统疾病的发病率不断上升，以及全球对微创治疗方案的需求不断增加，将推动全球儿童膀胱治疗市场的增长。

Data Bridge Market Research 分析了 2023-2030 年预测期内全球儿科膀胱治疗市场的增长率。在上述预测期内，全球鼻窦炎治疗药物市场的预期复合年增长率 趋于 4.00% 左右。2022 年市场价值为 34 亿美元，到 2030 年将增长到 46.5 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

儿童膀胱治疗市场范围和细分

Market Definition

The pediatric bladder is a type of urological disease that is most common in children under 3 years old. A sudden urge to urinate occurs in the patient. The symptoms of the disease include regular urinary tract infections and a sudden urge to urinate. As per the report, around 17 to 20% of children may face urine incontinence during the day, and a further 6.6% may face problems at night. 

Global Pediatric Bladder Treatment Market Dynamics

Drivers

• Increased Incidence of Pediatric Bladder

Pediatric bladder is a prevalent condition. Additionally, it's estimated that this condition affects about 30% of children at age 4, 10% at age 7, 3% at age 12, and 1% at age 18. Thus, it boosts market growth.

• Rising Healthcare Expenditure

The healthcare expenditure includes all testing devices, healthcare services, family planning activities, and emergency kits designated for health. The factors determining the healthcare expenditure of any country are income (per capita GDP), technological progress and variation in medical practice, and health system characteristics. This healthcare expenditure helps organizations and government bodies increase the research activities on bladder treatment drugs, their upcoming clinical trials, and R&D activities. Thus, it boosts market growth.

Opportunities

• Increased Drug Launches

There have been increased drug launches that are helping in expanding the market growth. For instance, in April 2021, Medtronic plc announced approval from the US FDA to proceed with an investigational device exemption (IDE) trial to evaluate its internally developed implantable tibial neuromodulation (TNM) device, which is a therapy designed to provide relief from symptoms of bladder incontinence.

• The rise in Pediatric Population

The rising pediatric population is the main factor driving the market growth. According to surveys, in 2022, there will be 2 billion children worldwide aged 0 to 14 years old. This factor is projected to create opportunities in the forecast period.

Restraints/Challenges

• Side Effects of Bladder Drugs

The side effects associated with these pediatric bladder drugs could limit the growth of the global market over a forecast period. Effects such as rashes, loss of appetite, fever, fatigue, and constipation can hamper the market growth.

• Lack of Skilled Professionals

The lack of healthcare professionals unable to diagnose the condition and treat the same can hamper the market growth. Trained professionals are required for faster identification of the disease and immediate treatment process so that the recovery can be faster.

This global pediatric bladder treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global pediatric bladder treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Pediatric Bladder Treatment Market Scope

The global pediatric bladder treatment market is segmented on the basis of type, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Diurnal Incontinence
• Enuresis
• Others

Treatment

• Urotherapy
• Medication
• Surgical Reconstruction
• Others

Route of Administration

• Oral
• Parenteral
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Pediatric Bladder Treatment Market Regional Analysis/Insights

The global pediatric bladder treatment market is analyzed and market size insights and trends are provided by type, treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global pediatric bladder treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing the highest pediatric bladder treatment market growth throughout the forecasted period due to increased government awareness programs and the number of generic drugs.

North America dominates the market due to the presence of key manufacturers of the product, high research and development and healthcare expenditure, and skilled professionals

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和全球儿童膀胱治疗市场份额分析

全球儿童膀胱治疗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球儿童膀胱治疗市场的关注有关。

全球儿童膀胱治疗市场的主要参与者包括：

• 辉瑞公司 (美国)
• 阿斯利康（英国）
• Endo International plc（爱尔兰）
• 梯瓦制药工业有限公司 (以色列)
• 太阳制药工业有限公司 (印度)
• Mylan NV（美国）
• 诺华公司（瑞士）
• Aurobindo Pharma（印度）
• 赛诺菲（法国）
• 武田药品工业株式会社 (日本)
• F. Hoffmann-La Roche Ltd（瑞士）
• Orion 公司 (芬兰)
• TherapeuticsMD, Inc.（美国）
• AbbVie Inc.（美国）
• AbbVie Inc.（美国）
• Bausch Health Companies Inc.（加拿大）
• Amneal Pharmaceuticals LLC.（美国）
• Apotex Inc.（加拿大）
• Aurobindo Pharma（印度）

研究方法：全球儿童膀胱治疗市场       

数据收集和基准年分析是使用具有大样本量的数据收集模块进行的。市场数据使用市场统计和连贯模型进行分析和估计。市场份额分析和关键趋势分析也是市场报告中的主要成功因素。如需了解更多信息，请请求分析师致电或下拉询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，涉及数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们很自豪能够为现有和新客户提供符合其目标的数据和分析。报告可以定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（Factbook）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

SKU-55702